PURPOSE: Adverse drug reactions (ADRs) are a major patient safety issue, and a substantial proportion of ADRs are, in fact, preventable. The aim of this study was to describe the proportion and pattern of preventable ADRs in spontaneously reported suspected ADRs and to study the feasibility of using data from an ADR reporting system for this purpose. METHODS: All reports of ADRs, except those in which a vaccine was the suspected drug, submitted to the regional pharmacovigilance center of southeastern Sweden between 2008 and 2009 were analyzed. Causality between the suspected ADR and the medication was assessed using the World Health Organization (WHO) criteria, and preventability was assessed using Hallas criteria. RESULTS: During the study period, 1,290 ADRs were received and 1,255 were classified as having at least a possible causality between a reaction and a drug. Of these, 172 (14%) ADRs were considered preventable, 35 (20%) were classified as definitely preventable, and 137 (80%) as possibly preventable. Of all preventable ADRs, 96 (56%) were related to prescribing, 35 (20%) to administration, and 41 (24%) to clinical and laboratory monitoring of treatment. Warfarin, oxycodone, and ioversol were the most common drugs with preventable ADRs. CONCLUSIONS: This study found that a substantial part of reported ADRs are preventable. Most of these are related to drug prescription, suggesting that interventions aiming to reduce preventable ADRs should focus on this process. Moreover, systems for ADR reporting may be useful in the mission of reducing the unsafe use of drugs.
PURPOSE: Adverse drug reactions (ADRs) are a major patient safety issue, and a substantial proportion of ADRs are, in fact, preventable. The aim of this study was to describe the proportion and pattern of preventable ADRs in spontaneously reported suspected ADRs and to study the feasibility of using data from an ADR reporting system for this purpose. METHODS: All reports of ADRs, except those in which a vaccine was the suspected drug, submitted to the regional pharmacovigilance center of southeastern Sweden between 2008 and 2009 were analyzed. Causality between the suspected ADR and the medication was assessed using the World Health Organization (WHO) criteria, and preventability was assessed using Hallas criteria. RESULTS: During the study period, 1,290 ADRs were received and 1,255 were classified as having at least a possible causality between a reaction and a drug. Of these, 172 (14%) ADRs were considered preventable, 35 (20%) were classified as definitely preventable, and 137 (80%) as possibly preventable. Of all preventable ADRs, 96 (56%) were related to prescribing, 35 (20%) to administration, and 41 (24%) to clinical and laboratory monitoring of treatment. Warfarin, oxycodone, and ioversol were the most common drugs with preventable ADRs. CONCLUSIONS: This study found that a substantial part of reported ADRs are preventable. Most of these are related to drug prescription, suggesting that interventions aiming to reduce preventable ADRs should focus on this process. Moreover, systems for ADR reporting may be useful in the mission of reducing the unsafe use of drugs.
Authors: Anna K Jönsson; Katja M Hakkarainen; Olav Spigset; Henrik Druid; Anne Hiselius; Staffan Hägg Journal: Pharmacoepidemiol Drug Saf Date: 2010-02 Impact factor: 2.890
Authors: Nils Kucher; Shannon Connolly; Joshua A Beckman; Lay Har Cheng; Kanella V Tsilimingras; John Fanikos; Samuel Z Goldhaber Journal: Arch Intern Med Date: 2004-10-25
Authors: Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl Journal: Drug Saf Date: 2007 Impact factor: 5.606
Authors: Klaas A Hartholt; Nathalie van der Velde; Caspar W N Looman; Martien J M Panneman; Ed F van Beeck; Peter Patka; Tischa J M van der Cammen Journal: PLoS One Date: 2010-11-12 Impact factor: 3.240
Authors: Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed Journal: PLoS One Date: 2009-02-11 Impact factor: 3.240
Authors: Louise E Bracken; Anthony J Nunn; Jamie J Kirkham; Matthew Peak; Janine Arnott; Rosalind L Smyth; Munir Pirmohamed; Mark A Turner Journal: PLoS One Date: 2017-01-03 Impact factor: 3.240
Authors: Timm Hecht; Anika C Bundscherer; Christoph L Lassen; Nicole Lindenberg; Bernhard M Graf; Karl-Peter Ittner; Christoph H R Wiese Journal: BMC Anesthesiol Date: 2015-08-01 Impact factor: 2.217
Authors: Diana M Rydberg; Lennart Holm; Ida Engqvist; Jessica Fryckstedt; Jonatan D Lindh; Carl-Olav Stiller; Charlotte Asker-Hagelberg Journal: PLoS One Date: 2016-09-13 Impact factor: 3.240